On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.

Greil R, Egle A, Villunger A. Leuk Lymphoma. 1998 Nov,31(5-6):477-90.

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

Thaler J, Hilbe W, Apfelbeck U, Linkesch W, Sill H, Seewann H, Pont J, Bernhart M, Stöger M, Niessner H, Abbrederis K, Geissler D, Hausmaninger H, Lin W, Ludwig H, Lang A, Duba C, Fluckinger T, Greil R, Grünewald K, Konwalinka G, Niederwieser D, et al. Leuk Res. 1997 Jan,21(1):75-80.

Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromes.

Zabernigg A, Hilbe W, Eisterer W, Greil R, Ludescher C, Thaler J. Leuk Lymphoma. 1997 Sep,27(1-2):137-43.

Fas (Apo-1/CD95) – Ligand expression on neoplastic plasma cells and its role for the expansion of the neoplastic clone.

Fridrik MA, Greil R, Hausmaninger H, Krieger O, Oppitz P, Stöger M, Klocker J, Neubauer M, Helm W, Pont J, Fazeny B, Hudec M, Simonitsch I, Radaszkiewicz T. Ann Hematol. 1997 Oct,75(4):135-40.

Expression of Apo-1/Fas (CD95), Bcl-2 Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.

Egle A, Villunger A, Marschitz I, Kos M, Hittmair A, Lukas P, GrГјnewald K, Greil R. Br J Haematol. 1997 May,97(2):418-28.

Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance.

Villunger A, Egle A, Marschitz I, Kos M, Böck G, Ludwig H, Geley S, Kofler R, Greil R. Blood. 1997 Jul 1,90(1):12-20.

The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.

Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, Auer B, Kofler R. FEBS Lett. 1997 Jan 27,402(1):36-40.

Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R. Cancer Res. 1997 Aug 15,57(16):3331-4.

Multimodal therapy in life-threatening cerebral lupus erythematosus: the benefit of cerebrospinal fluid pheresis.

Pfausler B, Bösch S, Grubwieser G, Vollert H, Greil R, Hagn C, Schmutzhard E. Int Arch Allergy Immunol. 1995 Aug,107(4):592-4.

Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia.

Sepp NT, Umlauft F, Illersperger B, GrГјnewald K, Schuler G, Greil R, Vogel W. Dermatology. 1995,191(1):43-5.